Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crescent Biopharma (CBIO) Depreciation and Depletion (2016 - 2026)

Crescent Biopharma (CBIO) has disclosed Depreciation and Depletion for 12 consecutive years, with $64000.0 as the latest value for Q1 2026.

  • For Q1 2026, Depreciation and Depletion changed N/A year-over-year to $64000.0; the TTM value through Mar 2026 reached $120000.0, up 216.48%, while the annual FY2025 figure was $84000.0, 138.81% up from the prior year.
  • Depreciation and Depletion hit $64000.0 in Q1 2026 for Crescent Biopharma, up from $54000.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $64000.0 in Q1 2026 and bottomed at $2000.0 in Q2 2025.
  • Average Depreciation and Depletion over 5 years is $41255.7, with a median of $44778.5 recorded in 2022.
  • Year-over-year, Depreciation and Depletion fell 9.72% in 2023 and then crashed 66.65% in 2024.
  • Crescent Biopharma's Depreciation and Depletion stood at $45718.0 in 2022, then crashed by 49.04% to $23297.0 in 2023, then tumbled by 37.25% to $14620.0 in 2024, then surged by 269.36% to $54000.0 in 2025, then increased by 18.52% to $64000.0 in 2026.
  • According to Business Quant data, Depreciation and Depletion over the past three periods came in at $64000.0, $54000.0, and $2000.0 for Q1 2026, Q4 2025, and Q2 2025 respectively.